Personalized mRNA Vaccine Shows 87% Survival Rate in Pancreatic Cancer Patients Six Years Later
Pancreatic cancer is one of the few diseases where even a diagnosis caught early enough for surgery still carries an 80 percent chance of the cancer coming back. Its five-year survival rate sits at around 13 percent. Decades of research have barely moved that number. Now, a personalized mRNA vaccine tested at Memorial Sloan Kettering…
